COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Prevalence of Peptic Ulcer Disease and Dietary Pattern among Students of a Private University in Nigeria
- Evaluation of Hematopoietic and Immune Toxicity in First-Generation (G1) Rats Following Maternal Thiacloprid Exposure During Gestation and Lactation, and the Protective Potential of Bitter Apricot Kernel Extract
- Enhancing Freshwater Fish Consumption in Algeria: A Study on the Nutritional and Sensory Attributes of Common Carp Sticks
- Hypertension in Moroccan adults: sociodemographic, lifestyle, and dietary risk factors
- Influence of Grain Size on the Agglomeration and Quality of Fine Couscous Derived from Decorticated White Sorghum Bicolor L.
- Effect of Sunlight Exposure and Packaging Materials on the Quality and Oxidative Stability of Commercial Vegetable Oils in Cameroon
- Cyclodextrins for UV Protection in Food, Beverages, and Agricultural Products: A Comprehensive Review
- Overview of Food Safety and Labeling Regulatory Frameworks in Morocco
- Effect of Citric Acid and Brine Pre-Treatment on Deodorization of Green Banana Flour
- An Observational Study on the Use of Manual Muscle Testing for Dietary Elimination in Food Sensitivity-Related Conditions
You may also start an advanced similarity search for this article.

NAJFNR is licensed under